These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19534693)

  • 21. Flexibility of the thrombin-activatable fibrinolysis inhibitor pro-domain enables productive binding of protein substrates.
    Valnickova Z; Sanglas L; Arolas JL; Petersen SV; Schar C; Otzen D; Aviles FX; Gomis-Rüth FX; Enghild JJ
    J Biol Chem; 2010 Dec; 285(49):38243-50. PubMed ID: 20880845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.
    Watanabe R; Wada H; Watanabe Y; Sakakura M; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Nobori T; Shiku H
    Thromb Res; 2001 Oct; 104(1):1-6. PubMed ID: 11583733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombin activatable fibrinolysis inhibitor: not just an inhibitor of fibrinolysis.
    Bajzar L; Jain N; Wang P; Walker JB
    Crit Care Med; 2004 May; 32(5 Suppl):S320-4. PubMed ID: 15118538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Argatroban enhances fibrinolysis by differential inhibition of thrombin-mediated activation of thrombin activatable fibrinolysis inhibitor and factor XIII.
    Nielsen VG; Kirklin JK
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):793-800. PubMed ID: 19002046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombin and fibrinolysis.
    Nesheim M
    Chest; 2003 Sep; 124(3 Suppl):33S-9S. PubMed ID: 12970122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lys 42/43/44 and Arg 12 of thrombin-activable fibrinolysis inhibitor comprise a thrombomodulin exosite essential for its antifibrinolytic potential.
    Wu C; Stafford AR; Fredenburgh JC; Weitz JI; Gils A; Declerck PJ; Kim PY
    Thromb Haemost; 2017 Jul; 117(8):1509-1517. PubMed ID: 28640323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)].
    Urano T
    Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):298-303. PubMed ID: 11215380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PI3-Kinase Inhibitor LY294002 Repressed the Expression of Thrombin-Activatable Fibrinolysis Inhibitor in Human Hepatoma HepG2 Cells.
    Masuda Y; Yazawa J; Makino Y; Takada K
    Biol Pharm Bull; 2015; 38(10):1529-35. PubMed ID: 26424017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe.
    Juhan-Vague I; Morange PE; Aubert H; Henry M; Aillaud MF; Alessi MC; Samnegård A; Hawe E; Yudkin J; Margaglione M; Di Minno G; Hamsten A; Humphries SE;
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):867-73. PubMed ID: 12006404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the gene encoding human thrombin-activatable fibrinolysis inhibitor by estrogen and progesterone.
    Garand M; Lin JH; Zagorac B; Koschinsky ML; Boffa MB
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):393-404. PubMed ID: 23429253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and/or intrauterine fetal growth retardation?
    Antovic JP; Rafik Hamad R; Antovic A; Blombäck M; Bremme K
    Thromb Haemost; 2002 Oct; 88(4):644-7. PubMed ID: 12362237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin-activatable fibrinolysis inhibitor binds to Streptococcus pyogenes by interacting with collagen-like proteins A and B.
    Påhlman LI; Marx PF; Mörgelin M; Lukomski S; Meijers JC; Herwald H
    J Biol Chem; 2007 Aug; 282(34):24873-81. PubMed ID: 17553807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A genome-wide exploration suggests an oligogenic model of inheritance for the TAFI activity and its antigen levels.
    Sabater-Lleal M; Buil A; Souto JC; Alamsy L; Borrell M; Lathrop M; Blangero J; Fontcuberta J; Soria JM
    Hum Genet; 2008 Aug; 124(1):81-8. PubMed ID: 18563448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of TAFI increases brain damage and microparticle generation after thrombolytic therapy in ischemic stroke.
    Orbe J; Alexandru N; Roncal C; Belzunce M; Bibiot P; Rodriguez JA; Meijers JC; Georgescu A; Paramo JA
    Thromb Res; 2015 Aug; 136(2):445-50. PubMed ID: 26118976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired healing of cutaneous wounds and colonic anastomoses in mice lacking thrombin-activatable fibrinolysis inhibitor.
    te Velde EA; Wagenaar GT; Reijerkerk A; Roose-Girma M; Borel Rinkes IH; Voest EE; Bouma BN; Gebbink MF; Meijers JC
    J Thromb Haemost; 2003 Oct; 1(10):2087-96. PubMed ID: 14521589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of thrombomodulin mutation causing defective thrombin binding with absence of protein C and TAFI activation.
    Okada M; Tominaga N; Honda G; Nishioka J; Akita N; Hayashi T; Suzuki K; Moriuchi H
    Blood Adv; 2020 Jun; 4(12):2631-2639. PubMed ID: 32556284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris.
    Brouwers GJ; Leebeek FW; Tanck MW; Wouter Jukema J; Kluft C; de Maat MP
    Thromb Haemost; 2003 Jul; 90(1):92-100. PubMed ID: 12876631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deficiency in thrombin-activatable fibrinolysis inhibitor (TAFI) protected mice from ferric chloride-induced vena cava thrombosis.
    Wang X; Smith PL; Hsu MY; Tamasi JA; Bird E; Schumacher WA
    J Thromb Thrombolysis; 2007 Feb; 23(1):41-9. PubMed ID: 17111204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life.
    Nagashima M; Yin ZF; Zhao L; White K; Zhu Y; Lasky N; Halks-Miller M; Broze GJ; Fay WP; Morser J
    J Clin Invest; 2002 Jan; 109(1):101-10. PubMed ID: 11781355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of enhanced endogenous fibrinolysis in thrombin activatable fibrinolysis inhibitor-deficient mice.
    Mao SS; Holahan MA; Bailey C; Wu G; Colussi D; Carroll SS; Cook JJ
    Blood Coagul Fibrinolysis; 2005 Sep; 16(6):407-15. PubMed ID: 16093731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.